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Abstract: C
 oeliac disease is characterised by inflammation of small intestinal mucosa accompanied by abnormal villous architecture.  It is now
accepted that some patients with positive coeliac serology tests may have minor mucosal lesions that may not be apparent on routine
histopathological analysis.   The aim of the study was to perform detailed examination of enterocyte morphology and cytoskeletal
structures using a high content analysis technology. Duodenal biopsies from 14 untreated and 10 treated coeliac patients and from
20 non-coeliac controls were examined.  Tissue sections from six patients (study group subjects) before and after the development
of gluten-sensitive enteropathy were also investigated. Immunohistochemical studies were performed on paraffin-embedded sections
using an anti-α-tubulin antibody. Significant differences in enterocyte morphology and intracellular cytoskeletal structures were demonstrated in patients with proven coeliac disease and in the study group subjects. These changes were present in study group biopsies
before evidence of enteropathy, as assessed by routine microscopy.  This is the first study to demonstrate detailed characteristics of
enterocyte morphology in coeliac patients using a high content analysis approach. The use of this technology allows a quantitative
analysis of enterocyte intracellular structures from routine biopsy material and permits detection of subtle changes that precede the
characteristic histological lesion.
Keywords: C
 oeliac disease • Endomysial antibodies • Enterocytes • Tubulin • High content analysis
	       © Versita Warsaw and Springer-Verlag Berlin Heidelberg. 	       

1. Introduction
Coeliac disease is a gluten sensitive enteropathy
characterised by inflammation of the small intestinal
mucosa, with a range of abnormal villous architecture
and crypt hyperplasia features [1-3]. However, several
studies have reported only minimal intestinal changes
in some patients with positive coeliac serology [4-6].
In a proportion of these patients, detailed histological
analysis reveals subtle histological abnormalities such
as nuclear disarray, irregular cell shape [7], and an
increased number of intraepithelial lymphocytes [4-6]
with this increase sometimes confined to the villous
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tip [8,9]. In this clinical setting, the diagnosis of coeliac
disease may be missed, unless the patient is regularly
monitored for more definitive evidence of gluten sensitive
enteropathy.
Cytoskeletal proteins are involved in essentially
all structural and dynamic aspects of the living cell,
including maintenance of cell shape, movement,
replication, apoptosis, differentiation and intracellular
signalling [10-12]. Disruption of cytoskeletal structures
can severely limit cell function, and if not reversed
can adversely affect cell integrity and viability [13-15].
Rearrangement of the cytoskeletal proteins is thought
to result in nuclear disarray and alteration of enterocyte
* E-mail: con.feighery@tcd.ie
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Patients (n)

Sex
Males

Females

Age, years
(range)

EMA status
Positive

Negative

UTCD

(14)

4

10

52 (35-74)

14

0

TCD

(10)

4

6

54 (31-57)

0

10

9

11

55 (33-82)

0

20

Non-coeliac controls

Table 1.

(20)

Demographic and serologic details of the coeliac groups and non-coeliac controls.

UTCD: untreated coeliac disease; TCD: treated coeliac disease; EMA: endomysial antibody

shape, described features of the coeliac lesion [7].
Many other pathological conditions also demonstrate
abnormalities in cytoskeletal proteins, including several
cardiovascular disease syndromes, neurodegeneration,
cancer, liver cirrhosis, pulmonary fibrosis, and skin
diseases [16-20].
The cytoskeleton of eukaryotic cells is composed
of three major protein families that form filamentous
structures running throughout the cell: microfilaments
consisting of different actin isoforms, microtubules
made of α- and β-tubulin, and the intermediate filaments
[10,11,21]. The actin network has been shown to play
an important role in gliadin-induced effects on intestinal
epithelial cells, demonstrated by both in vivo and in vitro
studies [22,23]. Moreover, when coeliac patients on a
gluten-free diet were exposed to gliadin, this resulted
in disarrangement of intestinal mucosal actin filaments
in vivo [24-26]. It has also been demonstrated that Zo-1
expression is reduced in the intestinal mucosa of patients
with active coeliac disease and this is associated with
a disrupted F-actin organization; these changes were
reversed by gluten free diet treatment [27].
In this study, a new technology called high content
analysis was used to study details of enterocyte
morphology and their tubulin cytoskeletal structures in
biopsy tissue from patients with coeliac disease. This
system is based on automated extraction of data from
cellular images and is proving to be an invaluable
tool for the investigation of cytoskeletal networks,
allowing study of their complex dynamic changes at
a qualitatively new level of detail [28]. Employing the
morphology explorer bioapplication tool Cellomics®, the
system has been used to quantify fluorescent images
of the cytoskeleton in the NIH 3T3 cell line [28]. In this
study, biopsy tissue from patients with coeliac disease,
patients with potential coeliac disease and from disease
control subjects was examined. It was hypothesized that
changes in cell morphology and cytoskeletal structures
might be present in enterocytes from patients with
potential coeliac disease, even before the development
of a histological lesion on routine microscopy.

Figure 1.

H&E stained sections demonstrating the routine histological image of the study group subjects with normal
duodenal mucosa (A) and after the intestinal lesion was
developed (B). (magnification x40).

2. Experimental Procedures
2.1. Patients

2.1.1. Coeliac subjects

Duodenal biopsies from two patient groups were
examined. These included untreated and treated coeliac
disease patients. The duodenal histology in 14 patients
with untreated disease, all with positive endomysial
antibody tests, demonstrated partial villous atrophy and
crypt hyperplasia. Ten further coeliac patients, treated
with a gluten free diet, were endomysial antibody
negative. Demographic and serological details of these
two patient groups are given in Table 1.

2.1.2. Non-coeliac subjects

The non-coeliac control group comprised 20 subjects
who had been investigated because of symptoms
of dyspepsia but had normal duodenal mucosa and
negative endomysial antibodies (Table 1).

2.1.3. Study group subjects

This group comprised six patients with positive
endomysial antibody tests who had an apparently normal
duodenal mucosa (Figure 1A); these patients presented
with symptoms consistent with malabsorption and are
259
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Pt.no

Age (years)

Sex

Symptoms

EMA

Hb

1

20

F

Anaemia

+

4.9

2

49

F

Bloating, dyspepsia, weight loss

+

13

3

67

F

Bloating, diarrhoea, dyspepsia

+

4

54

M

Fatigue

+

5

34

F

Anaemia, diarrhoea, fatigue

+

11

6

67

F

Weight loss

+

12

Table 2.

Ferritin
3.9
8.7
3.9

Age, sex, clinical symptoms and laboratory results in the study group subjects.

Ferritin (normal range = 20-300 μg/l); haemoglobin (Hb) (normal range=11-18 g/dl)
EMA: anti-endomysial antibody

referred to throughout the manuscript as the study group
subjects. Demographic, clinical and laboratory features
of these patients are presented in Table 2. Based on
their normal laboratory findings, none of these patients
were considered to have coeliac disease and they
were discharged to their primary care physicians. As
part of the study, follow up serological and histological
evaluation was performed after a mean of 7.5 years
(range 5-11 years). This revealed that these patients
continued to have positive coeliac serology and all had
developed a small intestinal lesion (ranging from partial
to total villous atrophy) suggestive of coeliac disease
(Figure 1B). The intestinal lesion was scored according
to a modified Marsh scale [29]. The original biopsies
in the six subjects were subsequently re-evaluated by
two blinded histopathologists and again considered to
be normal, except in the case of one patient in whom
the intra-epithelial lymphocyte count was increased.
Additional details concerning these patients have been
previously reported [30].

2.2. Ethics approval

Ethical approval for this study was granted by the
Joint Ethics Committee of St James’s Hospital, Dublin,
Ireland.

2.3. Immunofluorescent technique

2 µm-thick duodenal sections from paraffin-embedded
blocks were placed on uncoated glass slides and
dried overnight at 52°C. Sections were dewaxed and
rehydrated in a series of graded xylene and alcohol
solutions and subsequently immersed in phosphatebuffered saline solution (PBS) at pH 7.4. Sections were
then preheated for antigen retrieval in a microwave oven
in 0.1 M citrate buffer pH 6.0 for 20 minutes on high
power and cooled for 20 minutes at room temperature.
After immersing the prepared samples in PBS, the
sections were next incubated with anti-α-tubulin
antibody (clone B-5-1-2, Sigma, St Louis, MO) at 1:100
dilution in antibody buffer (0.05% bovine serum albumin
and 0.1 sodium azide in PBS) for 60 minutes at 4ºC.
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Sections were then incubated with Alexa® (Molecular
Probes, Eugene, OR) fluorescent conjugated secondary
antibody at 1:500 in dilution buffer for 30 minutes. Cell
nuclei were counterstained with 1mM Hoeschst 33258
(Sigma, St Louis, MO). After each antibody application,
sections were washed twice in PBS. Sections were
then mounted with DAKO fluorescent mounting media
(Sigma, St Louis, MO) and kept in the dark at 4ºC until
analysis. Negative control samples were incubated with
isotype-matched control immunoglobulins instead of
monoclonal antibodies.

2.4. Quantification and image acquisition

Once sections were stained and dried, slides were
attached onto the custom-modified slide holder
developed for imaging on the Cellomics® Kineticscan
reader. Three-colour image sets were acquired at 40x
dry lens magnification. Quantitative data from stored
digital images of the enterocytes were processed using
the morphology explorer bioapplication tool Cellomics®.
This bioapplication was optimized for cell morphology
analysis, including cytoskeletal rearrangements and
Hoechst-stained nuclei. “Virtual” scans were carried out
using specific assay parameters of fluorescent images of
the enterocytes in each histological section. These were
acquired and analyzed by proprietary image processing
algorithms.

2.5. Optimization of image acquisition

The morphology explorer bioapplication was originally
designed as a general tool that can perform a wide
range of measurements related to cell morphology. The
features and capabilities provide researchers with the
flexibility to design their own assays. However, to date,
this bioapplication has only been used to analyse cell
lines. In this study, a new application was developed
to allow examination of paraffin-embedded duodenal
sections, so that individual cells within selected tissue
areas could be analyzed in situ. A methodology was
devised so that a 96 well plate could be used as a slide
holder, with a system for identifying the duodenal tissue
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Measurements

Normal control
(non-coeliac) group

UTCD group

TCD group

SGS
(first D2 biopsies)

SGS
(second D2 biopsies)

Enterocyte length

67 pixels (65- 74)

53 pixels (47-59)

56 pixels (65-74)

57 pixels (47- 67)

57 pixels (49- 65)

Enterocyte width

11 pixels (10-12)

13 pixels (11 -14)

12 pixels (11-13)

11 pixels (9-12)

14 pixels (13-16)

Enterocyte tubulin
fibre angles degree

8.6 (7.8-9.4)

7.2 (6.5-7.8)

8.3 (7-9.7)

6.6 (5.3-8)

6.4 (5.2-7.5)

Enterocyte tubulin
fibre staining
intensity

174 pixels (124-220)

330 pixels (249-411)

230 pixels (150-310)

290 pixels (161-419)

373 pixels (201-545)

Enterocyte tubulin
fibre density

48 pixels (43-54)

64 pixels (59-69)

59 pixels (49-68)

65 pixels (52-77)

66 pixels (54-78)

Enterocyte nuclear
shape (roundness)

1.59 pixels (1.54-1.64)

1.28 pixels (1.25-1.31)

1.50 pixels (1.45-1.55)

1.38 pixels (1.27-1.48)

1.25 pixels (1.15-1.35)

Enterocyte nuclear
length width ratio

2.06 pixels (1.92-2.20)

1.48 pixels (1.42-1.53)

1.87 pixels (1.73-2.00)

1.78 pixels (1.61-1.93)

1.54 pixels (1.38-1.68)

Table 3.

Characteristics of enterocyte morphology and tubulin profiles in the patient groups.

UTCD: untreated coeliac disease patients; TCD: treated coeliac disease patients; SGS: study group subjects. Results are expressed as
mean and 95% confidence intervals.

Figure 2.

Algorithmic created images representing enterocyte length and width in small intestinal mucosa in the normal control group (noncoeliac) (A), Untreated coeliac disease (B) and in the study group subjects (first biopsy) (C). Red arrow represents the enterocyte length
and yellow arrow represents their width. (magnification x40). The enterocyte length and width was measured based on the tubulin fibre
staining using the optimized bioapplication tools.

region of interest (middle third of the villi) using a field map.
To examine enterocytes individually (Figure 2),
we used three different fluorescent channels, each
determining a specific morphological feature of the
enterocyte. Furthermore, we set up parameters to
examine whole cells and cytoskeletal fibre arrangement.
These parameters (background correction, smooth
factor in channel 1 and 2, object segmentation in
channel 1 and 2, fibre detection and fibre alignment
in channel 3) were activated simultaneously. Thus, we
were able to measure the cell length, width, nuclear
shape and the tubulin fibre profiles in each individual
enterocyte from the duodenal sections. In some
instances, enterocytes appeared to overlay each other;
however, using the morphology explorer bioapplication
tools it was possible to ensure that the measurement of
only single cells was calculated.

2.6. Statistical analysis

The 95% confidence intervals (CI) of the enterocyte’s
structure characterization and the tubulin fibre profiles
for all four patient groups were calculated. The MannWhitney U test was then used to assess the statistical
significance of differences. A P-value of <0.05 was
considered to be statistically significant.

3. Results
The approximate measurements of the enterocyte
shape were calculated based on the output features
from the algorithmic image of the gross pattern of
tubulin staining [28]. In each biopsy, a minimum of ten
enterocytes were examined. The mean and 95% CI of
enterocyte measurements and the tubulin fibre profiles
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Figure 3.
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Quantification data of enterocyte morphology and tubulin structures in the normal control (non-coeliac) group, untreated coeliac disease
patients (UTCD), treated coeliac disease patients (TCD) and in the study group subjects (SGS) (first and second duodenal biopsies).
(magnification x40). Differences between the groups were calculated using the Mann-Whitney U test.

B.M. Mohamed et al.

are summarized in Table 3. Results are expressed
as the mean and range in pixels. Likewise, details of
nuclear data are summarized in Table 3.

3.1. Enterocyte length

The enterocyte length was measured along the medial
axis of the cells. In biopsy tissue from normal (noncoeliac) subjects, the mean enterocyte length was 67
pixels (range 65-74; Figure 2A). The enterocyte length
was significantly reduced in all the patient groups
(Figure 3A): in the untreated coeliac patients (mean 53
pixels, p<0.000; Figure 2B), in treated coeliac patients
(mean 56 pixels, p<0.001) in the first biopsy of the study
group subjects (mean 57 pixels p<0.01; Figure 2C)
and in the second biopsy in the study group subjects
(mean 57 pixels, p<0.006). Of note, the results were not
statistically different within the all patient groups.

3.4. Enterocyte tubulin fibre staining intensity

In the tissue from normal (non-coeliac) subjects, the
mean intensity of enterocyte tubulin fibre staining was
174 pixels (range124-220). Staining intensity was
significantly greater in all the patient groups except in
the treated coeliac patients (Figure 3D): in the untreated
coeliac patients, the mean intensity was 330 pixels
(p<0.001); in the first biopsy in the study group, the
mean intensity was 290 pixels (p<0.04); in the second
biopsy in the study group, the mean intensity was 373
pixels (p<0.006). Within these three patient groups, no
significant difference in the level of staining intensity
was found (Table 3). The treated coeliac group, on the
other hand, did not show any difference in comparison
to the normal (non-coeliac) control group.

3.5. Enterocyte tubulin fibre density

Enterocyte width was measured perpendicular to the
middle axis of the cell. In the normal (non-coeliac)
subjects, the mean enterocyte width was 11 pixels
(range 9-12; Figure 2A). This was significantly lower
than that found in the untreated coeliac patients (mean
14 pixels, p<0.002; Figure 2B) and the second biopsy
in the study group subjects (mean 13 pixels, p<0.03;
Figure 2C). Interestingly, the enterocyte width in the
treated coeliac patients and in the initial biopsy of the
study group subjects was similar to the non-coeliac
control subjects (Figure 3B).

The surface area density is a texture measurement
which takes into account both the intensity variation and
spatial distribution of the pixels within the enterocytes.
In enterocytes from normal (non-coeliac) subjects, the
mean tubulin fibre density was 48 pixels (range 4354). Enterocyte tubulin fibre density was significantly
increased in all the patient groups, with the exception
of treated coeliac patients (Table 3): in the untreated
coeliac patients, the mean density value was 64 pixels
(p<0.001); in the first biopsy of the study group, the
mean density was 65 pixels (p<0.01); and in the second
biopsy of the study group subjects, the mean density
was 66 pixels (p<0.01; Figure 3E).

3.3. Enterocyte tubulin fibre angles

3.6. Nuclear shape (roundness)

3.2. Enterocyte width

Fibre angle measurement represents the degree of
intracellular branching of tubulin. These measurements
were performed based on the algorithmic referenced
angles. Normal cells containing radially oriented fibres,
such as tubulin fibres radiating from the cell center, have
large degree angles. This is what was found in the normal
(non-coeliac) columnar epithelial cells, which displayed
a high tubulin angle degree (mean 8.6: range 7.8-9.4).
Enterocyte tubulin fibre angles were significantly reduced
in all the patient groups, except in the treated coeliac
patients (Figure 3C); in the untreated coeliac patients,
the mean angle degree was 7.2 (p<0.010); in first biopsy
of the study group subjects, mean 6.6 (p<0.01); in the
second biopsy of the study group subjects, mean 6.4
(p<0.005). Furthermore, the treated coeliac patients
showed a significantly higher angle degree, mean 8.3,
than the untreated coeliac patients (p<0.04) and the
second biopsies in the study group subjects (p<0.02).

In the normal enterocyte, the nucleus has an elliptical
shape. The measurement of the nuclear shape is based
on the perimeter square area of the nucleus (P2A).
A higher nuclear P2A value is found in the nucleus of
normal columnar epithelial cells, reflecting their elliptical
shape. As the nuclear shape develops a more rounded
shape, the closer the P2A unit gets to a value of 1. This
feature was investigated in this study in the normal (noncoeliac) subjects and the patient groups (Figure 3F). In
the biopsies from non-coeliac subjects, the mean P2A
value was 1.59 pixels (range 1.54-1.64; Figure 4A).
The P2A values were significantly closer to one in all
the patient groups, in comparison to the non-coeliac
subjects (Figure 4A); in the untreated patients, mean
1.28 pixels (p<0.0001; Figure 4B); in the treated coeliac
patients mean 1.50 pixels (p<0.0001); in the first biopsy
of the study group subjects mean 1.38 pixels (p<0.001;
Figure 4C); and in the second biopsy of the study group
subjects mean 1.25 pixels (p<0.0003). Of interest, the
nuclear P2A values in the treated coeliac patients were
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Figure 4.

Algorithmic created images representing enterocyte nuclei (red) in small intestinal mucosa in the normal control
group (non-coeliac) (A), Untreated coeliac disease (B)
and in the study group subjects (first biopsy) (C).

significantly greater than the untreated coeliac patients
(p<0.001), than the first biopsy of the study group
subjects (p<0.01) and than the second biopsy in the
study group subjects (p<0.0002).

3.7. Nuclear length and width ratio (LWR)

The enterocyte nuclear length and width ratio (LWR)
was also examined based on the P2A. A high nuclear
LWR value is found in the nucleus of normal columnar
epithelial cells and in the biopsy tissue from the normal
(non-coeliac) subjects (Figure 3G), the mean nuclear
LWR was 2.01 pixels (range 1.92-2.20). In comparison
with the non-coeliac subjects, the nuclear LWR was
significantly reduced in the untreated coeliac patients,
mean 1.47 pixels (p<0.0001); in the first biopsy of the
study group, mean 1.78 pixels (p<0.01); and in the
second biopsy in the study group, mean 1.54 pixels
(p<0.0005). In the treated coeliac patients, nuclear
LWR was not significantly different from the non-coeliac
subjects.

4. Discussion
This is the first study to examine enterocyte morphology
in histological tissue sections using digitalized high
content analysis. This technology, in combination with
a bioapplication software package named morphology
explorer, was used to accurately quantify enterocyte
length and width, nuclear shape and both tubulin
fibre alignment and texture. Duodenal biopsy tissue
from patients with coeliac disease and from noncoeliac control subjects was examined. In addition,
histological sections from a group of patients with a
positive endomysial antibody test - before and after the
development of an observable duodenal histological
lesions (designated the “study group subjects”) - were
investigated. When these study group subjects were
originally investigated, no histological lesion was noted,
although this might have been due to the presence of
patchy disease [4-6] or when subtle abnormalities, only
264

detectable by immunohistochemistry, were present [30].
Significant differences in enterocyte morphology and
intracellular structures were demonstrated in all the
patient groups in comparison to the control subjects.
High content analysis was originally designed
to study cells in suspension [31-33] and there are
no previous reports of employing this technology to
examine cells in fixed tissue sections. In this study, we
were able to modify the technology and demonstrate a
new application for this system: This allowed detailed
analysis of cell morphology and intracellular cytoskeletal
structures of individual cells in tissue sections. This is
a considerable advance on computer aided image
analysis which, although helpful in tissue analysis, does
not allow for similar detailed examination of individual
cells [34,35].
A decrease in epithelial cell height and increase in cell
width are commonly described features of enterocytes
in coeliac disease [7]. Using high content analysis, a
statistically significant reduction in enterocyte length
(or height) was found in both untreated and treated
coeliac patient groups. Of interest, a similar reduction
in length was also evident in the study group subjects in
both sets of samples i.e. before an apparent histological
lesion and after the development of a lesion. In the case
of enterocyte width, a significant increase in width was
only present in the untreated coeliac patients and in the
second set of biopsies from the study group.
The shape of cell nuclei was a further morphological
feature, which was investigated in these biopsies. Earlier
studies employing high content analysis have reported
that the cell nucleus is a valid object for morphological
quantification [31-33]. In contrast to the elliptical
shape found in normal enterocytes, in coeliac disease
cell nuclei tend to have a more rounded appearance
[7]. Using the analytical system described here, this
observation was confirmed and it was demonstrated
that a significant shape alteration was found not only in
the coeliac biopsy tissue but also in both sets of biopsies
from the study group subjects. Based on this finding,
changes in nuclear shape appear to act as evidence of
the development of a coeliac lesion.
Tubulin is the major component of the microtubules
and with other cytoskeletal proteins forms the essential
structural framework of cells [12-36]. In this study,
enterocyte tubulin fibre parameters were analyzed,
including tubulin fibre angles, fibre staining intensity
and fibre density. Alteration of all these parameters
was found in the untreated coeliac patients and similar
significant alterations were observed in the initial and
repeat biopsies in the study group subjects. Interestingly,
significant changes were not observed in the treated
coeliac patient biopsies.
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The re-arrangement of intracellular tubulin may be
responsible for the alteration in enterocyte morphology
in the coeliac and study group subjects. This may
explain why these cells lose their columnar shape. It is
also possible that these changes may affect the cell:cell
adherence of intestinal epithelial cells, a well described
finding in coeliac disease [37-40]. The continuity of the
surface epithelium is maintained by tight junctions (zona
occulens) and by actin-rich connections (zona adherens
and zona maculens), which join the uppermost portions
of the cells. Tubulin is required for maintaining tight
junction adherence and this may occur via regulation of
F-actin [41]. Of interest, actin is a target of IgA autoantibodies in coeliac disease and the level of these
antibodies was found to correlate with the extent of
intestinal damage [42-43]. It has also been reported that
IgA anti-actin antibodies could possibly be used to detect
coeliac patients when they present with only patchy
intestinal lesions [44]. Recent studies in our laboratory
have revealed that smooth muscle alpha-actin may be
the principal antigenic target of these antibodies (J.
Dunne, personal communication).
Taken together, the results presented here suggest
that high content analysis is able to accurately detect
subtle morphological alterations in enterocytes, even
in patients with apparently normal histology on routine
microscopic examination. Thus, these changes may
be very early features of gut inflammation and it was
noteworthy that they were observed in the first duodenal
biopsy of the study group subjects. It was also of interest

that the alterations were not more pronounced after
a clear cut histological lesion had developed. These
findings are of value in understanding the pathogenesis
of coeliac disease and may point to a direct damaging
effect on enterocytes caused by gluten. It is also
important to note that enterocytes play a direct role in
the immune response and have been shown to produce
cytokines such as IL-6, IL-8 and IL-15 in response to
injury or infection, thereby affecting the function of other
immunocompetent cells [45].
In summary, this study demonstrates the value
of digitalized high content analysis of tissue sections
in coeliac disease. This novel technology could be
employed to identify patients with early onset gluten
sensitive enteropathy and could also help dissect
pathogenic events in coeliac disease at the sub-cellular
level.
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